TP53 and esophageal squamous cell carcinoma: Collectively, we uncovered that TP53 mutation observed in the whole ESCC stages exhibited diverse impacts during ESCC carcinogenesis, and MACF1 mutation had roles in promoting ESCC progression in the A-ESCC phase.